Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control
NCT ID: NCT07190807
Last Updated: 2025-11-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
70 participants
INTERVENTIONAL
2025-11-07
2029-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In addition, to compile real-world clinical outcomes in subjects with chronic, intractable low back and/or leg pain.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Time Varied Pulse (TVP)-SCS settings
Boston Scientific WaveWriter Alpha™ SCS Systems
Time Varied Pulse (TVP)-SCS settings
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Boston Scientific WaveWriter Alpha™ SCS Systems
Time Varied Pulse (TVP)-SCS settings
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with chronic pain of the trunk and/or limbs for at least 6 months.
* 18 years of age or older when written informed consent is obtained
* Able to independently read and complete all questionnaires and assessments provided in English.
* Signed a valid, IRB or EC approved informed consent form (ICF) provided in English.
Exclusion Criteria
* Significant cognitive impairment at Screening and Baseline visit that, in the opinion of the Investigator, would reasonably be expected to impair the study candidate's ability to participate in the study
* A female who is pregnant, lactating, or is of childbearing potential and planning to get pregnant during the study or not using adequate contraception.
* Participating (or intends to participate) in another drug or device clinical trial that may influence the data that will be collected for this study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boston Scientific Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Natalie M Bloom Lyons
Role: STUDY_DIRECTOR
Boston Scientific Corporation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Denver Back Pain Specialists
Greenwood, Colorado, United States
Fox Chase Pain Management
Trevose, Pennsylvania, United States
Institute of Precision Pain Medicine
Corpus Christi, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Boston Scientific Clinical Research
Role: primary
Boston Scientific Clinical Research
Role: primary
Boston Scientific Clinical Research
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A4116
Identifier Type: -
Identifier Source: org_study_id